
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Amlodipine | FAERS: 2 | US FAERS | |
| 2 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 3 | Atorvastatin | FAERS: 1 | US FAERS | |
| 4 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 5 | Everolimus | FAERS: 1 | US FAERS | |
| 6 | Levofloxacin | FAERS: 1 | US FAERS | |
| 7 | Norethindrone acetate and ethinyl estradiol | FAERS: 1 | US FAERS | |
| 8 | Prednisolone | FAERS: 1 | US FAERS | |
| 9 | apremilast | FAERS: 1 | US FAERS | |
| 10 | Etodolac | OFFSIDES | ||
| 11 | Medroxyprogesterone | OFFSIDES | ||
| 12 | Piperacillin, Tazobactam Drug Combination | OFFSIDES | ||
| 13 | Progesterone | OFFSIDES | ||
| 14 | Scopolamine | OFFSIDES | ||
| 15 | nimesulide | OFFSIDES | ||
| 16 | ropinirole | OFFSIDES | ||
| 17 | tizanidine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.